Shanghai Sureness Biotechnology Co., Ltd. announced that it will receive CNY 199.90 million in a equity round of funding on April 26, 2024. The transaction will include participation from returning investor Shanghai OPM Biosciences Co., Ltd for CNY 199.90 million. This has been approved in the 3rd session of its 2nd directorate and the 2nd session of its 2nd supervisory board of the Shanghai OPM Biosciences Co., Ltd. post-completion of the transaction, registered capital will increase from CNY20 million to CNY200 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33.42 CNY | +1.40% | -5.89% | -39.42% |
05-09 | OPM Biosciences' Shareholder to Cut Stake | MT |
04-29 | Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.42% | 517M | |
+2.87% | 94.22B | |
-4.08% | 37.76B | |
-13.64% | 32.5B | |
+73.38% | 27.75B | |
-11.72% | 16.13B | |
-1.43% | 14.19B | |
-11.67% | 11.42B | |
+190.36% | 11.06B | |
-52.61% | 9.09B |
- Stock Market
- Equities
- 688293 Stock
- News Shanghai OPM Biosciences Co., Ltd.
- Shanghai Sureness Biotechnology Co., Ltd. announced that it expects to receive CNY 199.9 million in funding from Shanghai OPM Biosciences Co., Ltd.